3 results
Approved WMOCompleted
To measure APC resistance and SHBG levels as indicators of the risk of venous thrombosis during use of the new developed combined oral contraceptive containing dienogest/estradiolvalerate (Qlaira®) compared with a combined oral contraceptive…
Approved WMOCompleted
Primary Objective:The primary safety objective of the study is to assess the safety and tolerability of REGN2477 in male and female patients with fibrodysplasia ossificans progressiva (FOP).The primary efficacy objective of the study is to assess…
Approved WMOCompleted
To obtain a time effect curve of prilocaine 2% hyperbaric for intrathecal use in day case surgery